CD8A and COVID-19: Several publications have reported that severe COVID-19 elicits drastic changes in the overall distribution and phenotypical landscape of circulating T cells, characterized by severe lymphopenia (preferentially affecting CD8 T cells) and widespread T cell activation (4–6).